Pfizer, BioNTech get fast-track from FDA for Covid-19 vaccines July 13, 2020 Auto Bot BioNTech, BioPharma, biopharma nl, New York, Pfizer, SARS-CoV-2, Vaccines 0 The companies anticipate releasing more clinical data from the BNT162 messenger RNA vaccine program and potentially starting a 30,000-participant Phase IIb/III study this month.